Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), sold 307,000 shares at $4.62 ($1.4M) on 2019-12-09, disclosed to the SEC on 2019-12-11.
Open-market sale of $1.4M ATRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.58 | 110,000 | $504K | 35.5% |
| 2 | $4.62 | 97,000 | $448K | 31.6% |
| 3 | $4.68 | 100,000 | $468K | 33.0% |
| Total | $4.63 avg | 307,000 | $1.4M | 100% |
| Filing → |
| ATRS | SELL | 2019-12-11 | $972K | — | Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2019-12-11 | $279K | — | Filing → |